The agency issued a Form 483 with 6 observations for Drug Substance, Drug Product units and Quality Control laboratories
Luforbec® 100/6 pMDI aims to provide comprehensive support to patients and healthcare professionals
CMOs showed an increasing reluctance to take on debt in 2022
This transformation will enable GE HealthCare to build a strong foundation for business growth
OncoVeryx-F, a proprietary test developed by PredOmix, is set to transform early-stage cancer detection
Approval to dramatically change CAR-T therapies landscape
PrecisionLife to analyse OXEGENE data to improve mechanistic understanding of endometriosis and identify novel drug targets to support the development of new personalised treatments
Introduces a line-up of brands targeting key therapeutic categories for its ophthalmology segment launc
Rare childhood cancer subtype, Ph+ ALL, is found in 3-4% of pediatric cases and 25% of adult cases
SHL Medical announces the acquisition of LCA Automation AG, a Swiss innovative automation solutions provider
Subscribe To Our Newsletter & Stay Updated
